About BIA Separations
BIA Separations is a company based in Villach (Austria) founded in 1998 was acquired by Sartorius in October 2020.. BIA Separations has raised $1.69 million across 2 funding rounds from investors including Sartorius, European Union and Meta Group. The company has 2 employees as of December 31, 2022. BIA Separations offers products and services including CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System. BIA Separations operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
- Headquarter Villach, Austria
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bia Separations Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BIA Separations
BIA Separations offers a comprehensive portfolio of products and services, including CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Columns for efficient purification of large biomolecules in bioprocessing.
Platforms for process development and analysis of biomolecules like pDNA and mRNA.
System for nucleic acid extraction and purification in biomanufacturing.
Funding Insights of BIA Separations
BIA Separations has successfully raised a total of $1.69M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $390.05 thousand completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $390,053
-
First Round
First Round
(21 Sep 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Grant - BIA Separations | Valuation |
investors |
|
| Sep, 2015 | Amount | Private Equity Round - BIA Separations | Valuation | META Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BIA Separations
BIA Separations has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sartorius, European Union and Meta Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused Seed to Growth stage VC firm investing in Europe
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Laboratory and biopharmaceutical equipment is developed for production processes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BIA Separations
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BIA Separations
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bia Separations Comparisons
Competitors of BIA Separations
BIA Separations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provides liquid chromatography solutions
|
|
| domain | founded_year | HQ Location |
Biomolecular separation technologies are enabled for bioprocessing applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bia Separations
Frequently Asked Questions about BIA Separations
When was BIA Separations founded?
BIA Separations was founded in 1998 and raised its 1st funding round 17 years after it was founded.
Where is BIA Separations located?
BIA Separations is headquartered in Villach, Austria. It is registered at Villach, Karnten, Austria.
Is BIA Separations a funded company?
BIA Separations is a funded company, having raised a total of $1.69M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $1.69M, raised on Sep 21, 2015.
How many employees does BIA Separations have?
As of Dec 31, 2022, the latest employee count at BIA Separations is 2.
What does BIA Separations do?
BIA Separations was established in 1998 in Villach, Austria, within the biotechnology sector. Proprietary short monolithic chromatographic columns are manufactured and distributed for laboratory and industrial use, relying on Convective Interaction Media (CIM) technology. These columns facilitate purification of large biomolecules, including viral vectors, vaccines, plasmid DNA, and proteins such as immunoglobulins G and M. Operations support research, pilot-scale, and production applications across biotechnology processes.
Who are the top competitors of BIA Separations?
BIA Separations's top competitors include ChromaTan, Sepragen and Sepax Technologies.
What products or services does BIA Separations offer?
BIA Separations offers CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System.
Who are BIA Separations's investors?
BIA Separations has 3 investors. Key investors include Sartorius, European Union, and Meta Group.